Slingsby Brian Taylor
SEC CIK 1963901 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Dir, 10% | 0 | $7.50M | $7.18M | 7 | 2023-02-14 | 2026-02-19 |
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Gold Alexander M | Dir | — | $1.58M |
| 8 | Karydas Daphne | Dir | — | $925.6K |
| 9 | Slingsby Brian Taylor | Dir, 10% | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | J - Other | $0.00 | -6,200 | 0 | -100% | $0 |
| DI | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | J - Other | $0.00 | +6,200 | 7.91M | +0.1% | $0 |
| D | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| I | 2025-04-25 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | P - Purchase | $13.50 | +259.3K | 8.90M | +3% | +$3.50M |
| I | 2024-07-26 | 2024-07-24 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | S - Sale | $13.05 | -550.0K | 8.64M | -6% | -$7.18M |
| DI | 2023-02-16 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | P - Purchase | $16.00 | +250.0K | 9.19M | +3% | +$4.00M |
| DI | 2023-02-16 | 2023-02-14 | MLYS | Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Dir, 10% | C - Cnv Deriv | — | +4.31M | 8.94M | +93% | — |
Purchase Sale Sale after option exercise All abbreviations